Company Information
Industry 制造业
Company Introduction 北京天坛生物制品股份有限公司是目前我国最大的生物制品研究和生产基地之一,是央企中国生物技术集团公司下辖的唯一的一家上市公司.公司主要从事疫苗、血液制剂、诊断用品等生物制品的研发、生产和销售,主导产品包括重组酵母乙型肝炎疫苗、风疹活疫苗、骨髓灰质炎疫苗、乙型脑炎灭活疫苗、麻风二联疫苗(MR)、各种诊断试剂等20多个品种,主营产品占有国内50%以上的市场份额.公司全部生产车间已通过了国家食品药品监督管理局(SFDA)的GMP认证,主要生产车间已达到国际先进水平.公司生产的H1N1流感疫苗获国家收储。
Main Business 血液制品的研发、生产和销售。
Legal Representative 付道兴
Top Executives
董事长:杨汇川
董事:何彦林,孙京林,刘亚娜,杨汇川,胡立刚
独立董事:顾奋玲,方燕,张木
Top 5 Shareholder
Shareholder name Nature Holding Date
中国生物技术股份有限公司流通A股45.64%30/09/2024
成都生物制品研究所有限责任公司流通A股3.53%30/09/2024
石雯流通A股2.79%30/09/2024
香港中央结算有限公司流通A股2.66%30/09/2024
中国工商银行股份有限公司-中欧医疗健康混合型证券投资基金流通A股2.03%30/09/2024
Company Secretary 张翼
Solicitors 北京市嘉源律师事务所
Auditors 天健会计师事务所(特殊普通合伙)
Tel No 010-65439720
Fax No 010-65436770
Website www.TiantanBio.com
Email ttsw@sinopharm.com
Company Address
Register: 北京市北京经济技术开发区博兴二路6号院8号楼521室
Office: 北京市朝阳区双桥路乙2号院A座一层
Listing Date 16/06/1998
Shares Capital
Shares Capital: 1,977,371,446
Total A Share: 1,977,371,446
Listed A Share: 1,977,371,446
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.670
DPS(RMB)* ¥ 0.150
NBV Per Share(RMB)* ¥ 5.961
Market Capitalization(RMB) 42.039B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.